Gapping up
In reaction to earnings/guidance:
- FTCH +23.7%, DE +3.6%, GLOB +0.9%
Other news:
- RCKT +4.3% (Presents Positive Data from LV Hematology and AAV Cardiovascular Gene Therapy Programs at the 26th Annual Meeting of the American Society of Gene and Cell Therapy)
- BSGM +3.4% (New Data at Heart Rhythm 2023 Suggests that Unipolar Signals May be Used for a More Precise Accurate Approach to Treating Arrhythmias)
- BCLI +2.9% (Summarizes Key Messages from Its Participation as Expert Speakers in an Invited Presentation and Panel Discussion at The 2023 ALS Drug Development Summit)
- LAZ +2.2% (CEO preparing to step down leaving job for Peter Orszag according to WSJ)
- MODV +2% (Resolves dispute with former CEO)
- CPE +1.4% (names new COO)
- AMAM +1.3% (names new chairman)
- NIO +1.2% (NIO and Autoliv (ALV) to develop safety technology for future electric vehicles)
- LYB +1.2% (increases quarterly dividend to $1.25 per share from $1.19 per share)
- AA +1.1% (union ratifies new collective bargaining agreement)
- OXY +1.1% (bought another 3457222 shares worth more than $201 mln)
- TXRH +1% (names new CFO) .
Analyst comments:
- BE +6.2% (upgraded to Overweight from Neutral at JP Morgan)
- LUNR +1.2% (initiated with an Overweight at Cantor Fitzgerald)
- PLNT +1.1% (initiated with an Outperform at RBC Capital Mkts)
- TEL +0.8% (upgraded to Outperform from Neutral at Credit Suisse)